Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium sodium phosphosilicate dentifrice for dentinal hypersensitivity
NCT01691560Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2012
- Primary completion
- Nov 2012
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of calcium sodium phosphosilicate in dentin hypersensitivity (DH), sponsored by GSK. Started Aug 2012; status: completed.
02
Drugs
calcium sodium phosphosilicate
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT01691560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691560.